PHR vs. MMS, EXLS, NVEI, ALIT, WU, CNXC, CBZ, ENV, ACVA, and DLO
Should you be buying Phreesia stock or one of its competitors? The main competitors of Phreesia include Maximus (MMS), ExlService (EXLS), Nuvei (NVEI), Alight (ALIT), Western Union (WU), Concentrix (CNXC), CBIZ (CBZ), Envestnet (ENV), ACV Auctions (ACVA), and DLocal (DLO). These companies are all part of the "business services, not elsewhere classified" industry.
Phreesia (NYSE:PHR) and Maximus (NYSE:MMS) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their community ranking, analyst recommendations, profitability, risk, institutional ownership, dividends, media sentiment, valuation and earnings.
Phreesia has a beta of 0.95, suggesting that its share price is 5% less volatile than the S&P 500. Comparatively, Maximus has a beta of 0.72, suggesting that its share price is 28% less volatile than the S&P 500.
In the previous week, Phreesia had 9 more articles in the media than Maximus. MarketBeat recorded 18 mentions for Phreesia and 9 mentions for Maximus. Maximus' average media sentiment score of 1.06 beat Phreesia's score of 0.27 indicating that Maximus is being referred to more favorably in the news media.
Phreesia presently has a consensus target price of $31.38, indicating a potential upside of 65.88%. Maximus has a consensus target price of $102.00, indicating a potential upside of 18.47%. Given Phreesia's stronger consensus rating and higher possible upside, analysts clearly believe Phreesia is more favorable than Maximus.
Maximus received 317 more outperform votes than Phreesia when rated by MarketBeat users. Likewise, 65.78% of users gave Maximus an outperform vote while only 65.46% of users gave Phreesia an outperform vote.
92.1% of Phreesia shares are held by institutional investors. Comparatively, 97.2% of Maximus shares are held by institutional investors. 5.8% of Phreesia shares are held by company insiders. Comparatively, 1.4% of Maximus shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
Maximus has higher revenue and earnings than Phreesia. Phreesia is trading at a lower price-to-earnings ratio than Maximus, indicating that it is currently the more affordable of the two stocks.
Maximus has a net margin of 4.58% compared to Phreesia's net margin of -31.87%. Maximus' return on equity of 18.02% beat Phreesia's return on equity.
Summary
Maximus beats Phreesia on 11 of the 18 factors compared between the two stocks.
Get Phreesia News Delivered to You Automatically
Sign up to receive the latest news and ratings for PHR and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding PHR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Phreesia Competitors List
Related Companies and Tools
